After stopping a CYP3A4 inducer, as the effects with the inducer decline, the buprenorphine plasma concentration will raise [see CLINICAL PHARMACOLOGY], which could increase or prolong both equally therapeutic effects and adverse reactions and could cause major respiratory despair.Use this medication frequently as a way to obtain the most reward fr